In today’s briefing:
- Steadfast (SDF AU): Amwins/Dragoneer/ KKR Firms $6/Share Scheme Offer. Looks Clean
- Auric Mining Limited – Study out with a game plan to action
- Island Pharmaceuticals Ltd – Second manufacturing campaign of Galidesivir for outbreak
- Universal Store Primed For Strong Growth
- Aussie Shorts [17 Aug 2026]: PLS Group, Woodside Energy, CAR Group, Xero, Wisetech Global
- Woodside Petroleum (WPL AU): Synthetic Expert Call Transcript (23 Aug 2026)
Steadfast (SDF AU): Amwins/Dragoneer/ KKR Firms $6/Share Scheme Offer. Looks Clean
- Back on the 10th June, Steadfast (SDF AU)entered into a process deal with Amwins/Dragoneer/KKR at A$6/share by way of a Scheme, a 51.9% premium to undisturbed.
- The suitors were provided with eight weeks of exclusive due diligence access, which was extended to the 21st August, all while telegraphing negotiations were progressing nicely.
- On the 21st August, Steadfast announced Amwins/Dragoneer/KKR had firmed their $6/share Scheme bid. Mid-late December implementation expected. The board is unanimous. The Offer price is not final.
Auric Mining Limited – Study out with a game plan to action
- Auric Mining Limited (ASX:AWJ) is a junior gold producer and developer that owns a portfolio of gold assets around the Kalgoorlie and Norseman regions of Western Australia (WA).
- The release of the Integrated Study is a major milestone for AWJ in becoming a standalone gold producer, with the study detailing attractive economics from a five-year operation.
- AWJ has net cash of ~$38m as of June 2026, which we think can support ongoing exploration, support further tolling opportunities, complementary asset acquisitions, and potentially provide a material contribution towards funding the Burbanks redevelopment.
Island Pharmaceuticals Ltd – Second manufacturing campaign of Galidesivir for outbreak
- Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
- ILA has commissioned a second manufacturing campaign of GMP-grade Galidesivir with PI Health Sciences, which will increase its available inventory to approximately 700-800 treatment courses in Q4 CY26.
- This inventory will improve ILA’s ability to rapidly respond to the active Bundibugyo Ebola outbreak, deploy Galidesivir under the MEURI framework and engage with government and biodefence agencies without waiting for a new manufacturing campaign.
Universal Store Primed For Strong Growth
- FY26 yet again highlighted Universal Store as a quality retail operator against an increasingly challenging macro backdrop.
- Universal Store defies a tough retail backdrop, catching shorters on the back foot Perfect Stranger emerges as a growth engine Record store rollout and market share gains underpin FY27 growth outlook
Aussie Shorts [17 Aug 2026]: PLS Group, Woodside Energy, CAR Group, Xero, Wisetech Global
- Australia’s ASIC releases the aggregated short position data four business days after the reporting day. Data in this insight is up to 17th August, published on the 21st August.
- The largest industry net increase in the past week was A$0.1bn into “Media/Services“; the largest industry net decrease was A$0.4bn out of “Banks“. Net shorts declined A$0.7bn week-on-week.
- Companies mentioned in this regular weekly report include: PLS Group (PLS AU), Woodside Energy Group (WDS AU), CAR Group (CAR AU), Xero Ltd (XRO AU), and Wisetech Global (WTC AU).
Woodside Petroleum (WPL AU): Synthetic Expert Call Transcript (23 Aug 2026)
- Louisiana LNG’s capital risk has been heavily mitigated by the twin sell-downs in 2025 to Stonepeak (40%) and Williams (10% HoldCo, 80% PipelineCo). This structural partnering shifted $7.6 billion in capital obligations away from Woodside’s balance sheet, though Woodside remains exposed to $11.8 billion in capex and is actively searching for a third partner to acquire a further 20% stake.
- Scarborough is on the home stretch at 98% complete as of mid-2026, with first gas achieved and first LNG cargo locked in for Q4 2026. This project is the linchpin for Woodside’s near-term deleveraging strategy, as it must generate substantial free cash flow to offset a balance sheet currently carrying $9.3 billion in net debt and a 21% gearing ratio.
- Decommissioning liabilities are an immediate cash drain, with a US$6.89 billion restoration provision on the balance sheet as of Dec 31, 2025 and guided spend of US$500 to US$800 million for 2026 alone. This liability remains highly sensitive to regulatory changes, specifically NOPSEMA’s strict insistence on full removal over in-situ abandonment, which could drive long-term costs significantly higher.
Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
